Search research articles
Contact Us
Filters
Showing results (81-90 of 107) with videos related to
Page
of 11
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 14, 2003
Combined treatment with arsenic trioxide and all-trans-retinoic acid in patients with relapsed acute promyelocytic leukemia
Emmanuel Raffoux, Philippe Rousselot, Jöel Poupon, et al.
Journal of Hematology & Oncology
|
January 29, 2016
GEP analysis validates high risk MDS and acute myeloid leukemia post MDS mice models and highlights novel dysregulated pathways
Laura Guerenne, Stéphanie Beurlet, Mohamed Said, et al.
Oncotarget
|
September 18, 2015
DNA-mediated adjuvant immunotherapy extends survival in two different mouse models of myeloid malignancies
Carole Le Pogam, Satyananda Patel, Petra Gorombei, et al.
Plos One
|
February 4, 2010
Interlaboratory development and validation of a HRM method applied to the detection of JAK2 exon 12 mutations in polycythemia vera patients
Valerie Ugo, Sylvie Tondeur, Marie-Laurence Menot, et al.
Leukemia
|
November 29, 2019
Despite mutation acquisition in hematopoietic stem cells, JMML-propagating cells are not always restricted to this compartment
Aurélie Caye, Kevin Rouault-Pierre, Marion Strullu, et al.
Leukemia
|
February 2, 2020
Correction: Despite mutation acquisition in hematopoietic stem cells, JMML-propagating cells are not always restricted to this compartment
Aurélie Caye, Kevin Rouault-Pierre, Marion Strullu, et al.
Blood
|
April 1, 2004
Health, economic, and quality-of-life effects of erythropoietin and granulocyte colony-stimulating factor for the treatment of myelodysplastic syndromes: a randomized, controlled trial
Nicole Casadevall, Pierre Durieux, Stéphanie Dubois, et al.
Journal of Medical Genetics
|
August 7, 2014
Juvenile myelomonocytic leukaemia and Noonan syndrome
Marion Strullu, Aurélie Caye, Julie Lachenaud, et al.
Frontiers in Immunology
|
July 3, 2018
Arsenic Trioxide Enhances the NK Cell Cytotoxicity Against Acute Promyelocytic Leukemia While Simultaneously Inhibiting Its Bio-Genesis
Ansu Abu Alex, Saravanan Ganesan, Hamenth Kumar Palani, et al.
Oncotarget
|
February 5, 2011
Phase 2 clinical trial of 5-azacitidine, valproic acid, and all-trans retinoic acid in patients with high-risk acute myeloid leukemia or myelodysplastic syndrome
Emmanuel Raffoux, Audrey Cras, Christian Recher, et al.
Page
of 11
Search research articles
Search
Showing results (81-90 of 107) with videos related to
Sort By:
Page
of 11
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 14, 2003
Combined treatment with arsenic trioxide and all-trans-retinoic acid in patients with relapsed acute promyelocytic leukemia
Emmanuel Raffoux, Philippe Rousselot, Jöel Poupon, et al.
Journal of Hematology & Oncology
|
January 29, 2016
GEP analysis validates high risk MDS and acute myeloid leukemia post MDS mice models and highlights novel dysregulated pathways
Laura Guerenne, Stéphanie Beurlet, Mohamed Said, et al.
Oncotarget
|
September 18, 2015
DNA-mediated adjuvant immunotherapy extends survival in two different mouse models of myeloid malignancies
Carole Le Pogam, Satyananda Patel, Petra Gorombei, et al.
Plos One
|
February 4, 2010
Interlaboratory development and validation of a HRM method applied to the detection of JAK2 exon 12 mutations in polycythemia vera patients
Valerie Ugo, Sylvie Tondeur, Marie-Laurence Menot, et al.
Leukemia
|
November 29, 2019
Despite mutation acquisition in hematopoietic stem cells, JMML-propagating cells are not always restricted to this compartment
Aurélie Caye, Kevin Rouault-Pierre, Marion Strullu, et al.
Leukemia
|
February 2, 2020
Correction: Despite mutation acquisition in hematopoietic stem cells, JMML-propagating cells are not always restricted to this compartment
Aurélie Caye, Kevin Rouault-Pierre, Marion Strullu, et al.
Blood
|
April 1, 2004
Health, economic, and quality-of-life effects of erythropoietin and granulocyte colony-stimulating factor for the treatment of myelodysplastic syndromes: a randomized, controlled trial
Nicole Casadevall, Pierre Durieux, Stéphanie Dubois, et al.
Journal of Medical Genetics
|
August 7, 2014
Juvenile myelomonocytic leukaemia and Noonan syndrome
Marion Strullu, Aurélie Caye, Julie Lachenaud, et al.
Frontiers in Immunology
|
July 3, 2018
Arsenic Trioxide Enhances the NK Cell Cytotoxicity Against Acute Promyelocytic Leukemia While Simultaneously Inhibiting Its Bio-Genesis
Ansu Abu Alex, Saravanan Ganesan, Hamenth Kumar Palani, et al.
Oncotarget
|
February 5, 2011
Phase 2 clinical trial of 5-azacitidine, valproic acid, and all-trans retinoic acid in patients with high-risk acute myeloid leukemia or myelodysplastic syndrome
Emmanuel Raffoux, Audrey Cras, Christian Recher, et al.
Page
of 11